Ramachandran S. Vasan

Cardiology and Cardiovascular Medicine · 2000–2019

A researcher in the Science corpus: 57 papers; trusts 16 researchers and is trusted by 23 researchers here, as inferred from the citation graph.

Subfields

Whom Ramachandran S. Vasan trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Ralph B. D’Agostino
  2. Michael J. Pencina
  3. Michael Olivier
  4. James A. Hanley
  5. S. Lewington
  6. P. Ridker
  7. Peter W. F. Wilson
  8. John Danesh
  9. R. Prentice
  10. Denis Noble

Who trusts Ramachandran S. Vasan overall

  1. C. Yancy
  2. Véronique L. Roger
  3. D. Lloyd‐Jones
  4. Michael F. O'Rourke
  5. Peter Libby
  6. Michael J. Pencina
  7. M. Zile
  8. Jay P. Singh
  9. Ewout W. Steyerberg
  10. Karel G. M. Moons

Papers from Ramachandran S. Vasan's perspective

Ordered by how strongly the researchers Ramachandran S. Vasan trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. (The Lancet)
  2. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. (American Journal of Kidney Diseases)
  3. Common SNPs explain a large proportion of heritability for human height (Nature Genetics)
  4. Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). (Circulation)
  5. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. (Journal of the American College of Cardiology)
  6. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap (Bioinform.)
  7. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.
  8. Next-generation genotype imputation service and methods (Nature Genetics)
  9. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. (American Journal of Epidemiology)
  10. Control of the mean number of false discoveries, Bonferroni and stability of multiple testing

Their papers